Allysta Pharmaceuticals, Inc.
Developing Novel Therapies for Eye Diseases
Allysta Pharmaceuticals, Inc., is a privately-held biopharmaceutical company based in the San Francisco Bay Area with a focus in ophthalmology, particularly dry eye disease and glaucoma. We have developed a novel first-in-class approach to reducing the inflammation that drives dry eye disease that targets adiponectin. We are also developing a novel multi-kinase for glaucoma. We expect to enter clinical testing for both in 2018.